Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018

Author's Avatar
Jun 27, 2018
Article's Main Image

Patient enrollment in the two TRILOGY Phase 3 studies is progressing as planned: 463 patients enrolled and 41 patients randomized at 110 clinical sites as of June 26th